Changes in adult obesity trends in the US

JAMA Health Forum

2024-12-13

(Press-News.org) About The Study: The findings of this study suggest that body mass index and obesity prevalence in the U.S. decreased in 2023 for the first time in more than a decade. The most notable decrease was in the South, which had the highest observed per capita glucagon-like peptide 1 receptor agonist (GLP-1RA) dispensing rate. However, dispensing does not necessarily mean uptake, and the South also experienced disproportionately high COVID-19 mortality among individuals with obesity.

Corresponding Author: To contact the corresponding author, Benjamin Rader, PhD, MPH, email benjamin.rader@childrens.harvard.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamahealthforum.2024.3685)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2024.3685?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121324

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

END

ELSE PRESS RELEASES FROM THIS DATE:

Prevalence of post–COVID-19 condition and activity-limiting post–COVID-19 condition among adults

2024-12-13

About The Study: In 2023, among 29,522 respondents to the National Health Interview Survey, a nationally representative household survey, 8.4% of adults in the U.S. reported they ever had post–COVID-19 condition (PCC; also known as long COVID), 3.6% currently had PCC, and 2.3% currently had activity-limiting PCC. Significant differences across all 3 outcomes were observed by sex, sexual orientation, age, race and Hispanic origin, family income, and urbanization. Corresponding Author: To contact the corresponding author, Anjel Vahratian, PhD, MPH, email avahratian@cdc.gov. To access the embargoed study: Visit our For The Media website ...

Scientists innovate breeding strategies to create climate-smart crops

2024-12-13

A recent study has reported a novel breeding strategy to rapidly create climate-smart crops that show higher yield under normal conditions and greatly rescue yield losses under heat stress both in staple grain and vegetable crops. The study, which was published in Cell on 13 December, was conducted by Prof. XU Cao’s team from the Institute of Genetics and Developmental Biology (IGDB) of the Chinese Academy of Sciences. The year 2050 is fast approaching and farm productivity must increase by 60% in order to feed a projected global population of 10 billion. However, current crop production is insufficient and is expected to worsen due to the abiotic-stress burden ...

The genetic basis of fertility, family and longevity

2024-12-13

Led by researchers from the University of Oxford’s Leverhulme Centre for Demographic Science and the University of Iceland, the review explores how genetic variations can explain differences in reproductive health and longevity. The study provides the most comprehensive review of male and female genetic discoveries of reproductive traits to date, and provides new insights into how our DNA affects when we have children, the timing of menopause, and even how that is connected to how long we live. Genes at the heart of reproduction Using the GWAS Catalog, an online database of Genome Wide Association Studies (GWAS), the researchers identified ...

Exposure to remote wildfire smoke drifting across the US linked to increased medical visits for heart and lung problems

2024-12-13

Wildfire smoke has long been known to exacerbate health problems like heart disease, lung conditions, and asthma, but now a new study finds that smoke from these fires can lead to poor health thousands of miles away. Researchers from the University of Maryland Institute for Health Computing (UM-IHC) found that medical visits for heart and lung problems rose by nearly 20 percent during six days in June, 2023, when smoke from Western Canadian wildfires drifted across the country, leading to very poor air quality days in Baltimore and ...

Northwestern University joins Giant Magellan Telescope International Consortium

2024-12-13

PASADENA, CA – December 13, 2024 – The Giant Magellan Telescope announced today that Northwestern University has joined its international consortium to construct the $2.54 billion observatory. Home to the world-renowned Center for Interdisciplinary Exploration and Research in Astrophysics (CIERA) and the newly founded NSF-Simons AI Institute for the Sky (SkAI), Northwestern is at the forefront of advancing astrophysical research. Northwestern researchers will develop and apply cutting-edge artificial intelligence ...

HR-positive, HER2-negative breast cancer patients with high risk of recurrence may benefit from addition of anthracyclines to taxane- based chemotherapy

2024-12-13

SAN ANTONIO – Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk of recurrence based on the OncotypeDX genomic test had better outcomes when treated with adjuvant anthracycline- plus taxane-based chemotherapy regimens compared with those receiving adjuvant taxane-based chemotherapy regimens alone, according to results presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024. “HR-positive, HER2-negative is the most common type of breast cancer in the United States and we frequently need to decide whether or not adjuvant chemotherapy ...

ZEST trial offers insights for using ctDNA to predict breast cancer recurrence

2024-12-13

SAN ANTONIO – The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients with circulating tumor DNA (ctDNA), failed to accrue enough patients positive for ctDNA, according to results presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024. As some of the lessons learned from this trial, investigators suggest beginning ctDNA testing during treatment rather than waiting for treatment completion as done in ZEST, and including patients with high- risk ...

Multimodal machine learning model effective at predicting response to CDK4/6 inhibitors in HR-positive, HER2-negative breast cancer patients

2024-12-13

SAN ANTONIO – A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either clinical or genomic data in predicting which patients with hormone receptor (HR)-positive, HER2-negative metastatic breast cancer would have better outcomes from adding CDK4/6 inhibitors to endocrine therapy as first-line treatment, according to results presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024. While the use of CDK4/6 inhibitors combined with endocrine therapy have significantly improved outcomes in patients with HR-positive, ...

Light-induced gene therapy disables cancer cells’ energy center

2024-12-13

COLUMBUS, Ohio – Researchers are shining a light on cancer cells’ energy centers – literally – to damage these power sources and trigger widespread cancer cell death. In a new study, scientists combined strategies to deliver energy-disrupting gene therapy using nanoparticles manufactured to zero in only on cancer cells. Experiments showed the targeted therapy is effective at shrinking glioblastoma brain tumors and aggressive breast cancer tumors in mice. The research team overcame a significant challenge to break ...

MLB adds lifesavers to the chain of survival at annual Winter Meetings

2024-12-13

DALLAS, December 13, 2024 — The American Heart Association and Major League Baseball (MLB) brought cardiopulmonary resuscitation (CPR) and automated external defibrillator (AED) training to the League’s annual Winter Meetings held in Dallas this week. Attendees from all 30 Major League Clubs and many organizations across the baseball industry learned lifesaving skills needed to respond confidently and capably in the event of a cardiac emergency. According to American Heart Association data, 9 out of ...

Changes in adult obesity trends in the US

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: